Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
14510 | 765 | 39.0 | 77% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
3 | 4 | PLANT SCIENCES//AGRONOMY//FOOD SCIENCE & TECHNOLOGY | 1882812 |
354 | 3 | MICROCYSTIN//HARMFUL ALGAE//MICROCYSTIN LR | 34996 |
1803 | 2 | LANTIBIOTIC//OXAZOLE//DOLASTATIN 10 | 6283 |
14510 | 1 | DOLASTATIN 10//DIDEMNIN B//CRYPTOPHYCIN | 765 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DOLASTATIN 10 | authKW | 1143846 | 4% | 87% | 33 |
2 | DIDEMNIN B | authKW | 1048987 | 4% | 91% | 29 |
3 | CRYPTOPHYCIN | authKW | 920363 | 4% | 82% | 28 |
4 | TZT 1027 | authKW | 899391 | 3% | 87% | 26 |
5 | PLITIDEPSIN | authKW | 704078 | 3% | 84% | 21 |
6 | DOLASTATIN | authKW | 676178 | 3% | 71% | 24 |
7 | APLIDIN | authKW | 528271 | 2% | 88% | 15 |
8 | APLIDINE | authKW | 524319 | 2% | 77% | 17 |
9 | KAHALALIDE F | authKW | 427643 | 2% | 71% | 15 |
10 | DIDEMNINS | authKW | 307027 | 1% | 77% | 10 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 2352 | 30% | 0% | 227 |
2 | Chemistry, Medicinal | 2156 | 16% | 0% | 124 |
3 | Chemistry, Organic | 2037 | 24% | 0% | 185 |
4 | Pharmacology & Pharmacy | 1156 | 24% | 0% | 186 |
5 | Biochemical Research Methods | 50 | 4% | 0% | 28 |
6 | Chemistry, Multidisciplinary | 44 | 8% | 0% | 62 |
7 | Biochemistry & Molecular Biology | 26 | 10% | 0% | 75 |
8 | Integrative & Complementary Medicine | 13 | 1% | 0% | 5 |
9 | Plant Sciences | 11 | 3% | 0% | 26 |
10 | Chemistry, Analytical | 11 | 3% | 0% | 25 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SOCIEDAD UNIPERSONAL | 119742 | 0% | 100% | 3 |
2 | CANC CANC CHEMOTHER Y TOSHIMA KU | 79828 | 0% | 100% | 2 |
3 | SOC UNIPERSONAL | 79828 | 0% | 100% | 2 |
4 | COLMENAR VIEJO | 76752 | 1% | 38% | 5 |
5 | POLIGONO IND LA MINA | 63858 | 1% | 40% | 4 |
6 | NDDO | 59868 | 0% | 50% | 3 |
7 | PHARMA MAR | 53217 | 0% | 67% | 2 |
8 | BIOMED SPECIAL SURG SCI SURG EXPT MED | 39914 | 0% | 100% | 1 |
9 | BIOPHARMACEUT SHANDONG | 39914 | 0% | 100% | 1 |
10 | BIOPHYS 1 | 39914 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INVESTIGATIONAL NEW DRUGS | 14045 | 4% | 1% | 30 |
2 | MARINE DRUGS | 9940 | 3% | 1% | 22 |
3 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 3367 | 3% | 0% | 25 |
4 | ANTI-CANCER DRUGS | 1462 | 1% | 0% | 11 |
5 | JOURNAL OF NATURAL PRODUCTS | 1438 | 3% | 0% | 21 |
6 | JOURNAL OF ORGANIC CHEMISTRY | 1195 | 5% | 0% | 40 |
7 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 953 | 3% | 0% | 25 |
8 | TETRAHEDRON | 805 | 4% | 0% | 28 |
9 | JOURNAL OF CARBOHYDRATES-NUCLEOSIDES-NUCLEOTIDES | 686 | 0% | 2% | 1 |
10 | CLINICAL CANCER RESEARCH | 663 | 2% | 0% | 16 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DOLASTATIN 10 | 1143846 | 4% | 87% | 33 | Search DOLASTATIN+10 | Search DOLASTATIN+10 |
2 | DIDEMNIN B | 1048987 | 4% | 91% | 29 | Search DIDEMNIN+B | Search DIDEMNIN+B |
3 | CRYPTOPHYCIN | 920363 | 4% | 82% | 28 | Search CRYPTOPHYCIN | Search CRYPTOPHYCIN |
4 | TZT 1027 | 899391 | 3% | 87% | 26 | Search TZT+1027 | Search TZT+1027 |
5 | PLITIDEPSIN | 704078 | 3% | 84% | 21 | Search PLITIDEPSIN | Search PLITIDEPSIN |
6 | DOLASTATIN | 676178 | 3% | 71% | 24 | Search DOLASTATIN | Search DOLASTATIN |
7 | APLIDIN | 528271 | 2% | 88% | 15 | Search APLIDIN | Search APLIDIN |
8 | APLIDINE | 524319 | 2% | 77% | 17 | Search APLIDINE | Search APLIDINE |
9 | KAHALALIDE F | 427643 | 2% | 71% | 15 | Search KAHALALIDE+F | Search KAHALALIDE+F |
10 | DIDEMNINS | 307027 | 1% | 77% | 10 | Search DIDEMNINS | Search DIDEMNINS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MOLINSKI, TF , DALISAY, DS , LIEVENS, SL , SALUDES, JP , (2009) DRUG DEVELOPMENT FROM MARINE NATURAL PRODUCTS.NATURE REVIEWS DRUG DISCOVERY. VOL. 8. ISSUE 1. P. 69 -85 | 110 | 44% | 400 |
2 | LEE, J , CURRANO, JN , CARROLL, PJ , JOULLIE, MM , (2012) DIDEMNINS, TAMANDARINS AND RELATED NATURAL PRODUCTS.NATURAL PRODUCT REPORTS. VOL. 29. ISSUE 3. P. 404 -424 | 81 | 84% | 27 |
3 | VERA, MD , JOULLIE, MM , (2002) NATURAL PRODUCTS AS PROBES OF CELL BIOLOGY: 20 YEARS OF DIDEMNIN RESEARCH.MEDICINAL RESEARCH REVIEWS. VOL. 22. ISSUE 2. P. 102 -145 | 91 | 78% | 84 |
4 | EISSLER, S , STONCIUS, A , NAHRWOLD, M , SEWALD, N , (2006) THE SYNTHESIS OF CRYPTOPHYCINS.SYNTHESIS-STUTTGART. VOL. . ISSUE 22. P. 3747-3789 | 74 | 84% | 12 |
5 | KITAGAKI, J , SHI, GB , MIYAUCHI, S , MURAKAMI, S , YANG, YL , (2015) CYCLIC DEPSIPEPTIDES AS POTENTIAL CANCER THERAPEUTICS.ANTI-CANCER DRUGS. VOL. 26. ISSUE 3. P. 259 -271 | 70 | 58% | 5 |
6 | WEISS, C , SAMMET, B , SEWALD, N , (2013) RECENT APPROACHES FOR THE SYNTHESIS OF MODIFIED CRYPTOPHYCINS.NATURAL PRODUCT REPORTS. VOL. 30. ISSUE 7. P. 924 -940 | 54 | 81% | 9 |
7 | DANU, A , WILLEKENS, C , RIBRAG, V , (2013) PLITIDEPSIN: AN ORPHAN DRUG.EXPERT OPINION ON ORPHAN DRUGS. VOL. 1. ISSUE 7. P. 569 -580 | 42 | 100% | 1 |
8 | NAHRWOLD, M , EISSLER, S , SEWALD, N , (2008) CRYPTOPHYCINS - HIGHLY CYTOTOXIC DEPSIPEPTIDES - HIGHLIGHTS, CHALLENGES, AND RECENT ADVANCES.CHIMICA OGGI-CHEMISTRY TODAY. VOL. 26. ISSUE 4. P. 13-16 | 52 | 91% | 0 |
9 | ALONSO-ALVAREZ, S , PARDAL, E , SANCHEZ-NIETO, D , NAVARRO, M , CABALLERO, MD , MATEOS, MV , MARTIN, A , (2017) PLITIDEPSIN: DESIGN, DEVELOPMENT, AND POTENTIAL PLACE IN THERAPY.DRUG DESIGN DEVELOPMENT AND THERAPY. VOL. 11. ISSUE . P. 253 -264 | 35 | 90% | 0 |
10 | PILARD, F , MEZRAI, A , DRICI, W , LESUR, D , MULENGI, JK , WADOUACHI, A , (2014) THE SYNTHESIS OF AN AZIRIDINYL ANALOGUE OF UNIT A OF CRYPTOPHYCIN-1.LETTERS IN ORGANIC CHEMISTRY. VOL. 11. ISSUE 4. P. 259 -267 | 41 | 79% | 0 |
Classes with closest relation at Level 1 |